Tang, Sydney C W <br/><br/>
Aliskiren combined with losartan in immunoglobulin A nephropathy: an open-labeled pilot study.  [electronic resource] 

 -  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association  Feb 2012 
 - 613-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2385 
<br/><br/><label>Standard No.: </label>10.1093/ndt/gfr349  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Amides--adverse effects<br/>Antihypertensive Agents--adverse effects<br/>Confidence Intervals<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Female<br/>Follow-Up Studies<br/>Fumarates--adverse effects<br/>Glomerulonephritis, IGA--diagnosis<br/>Hong Kong<br/>Humans<br/>Interleukin-6--analysis<br/>Kidney Function Tests<br/>Losartan--adverse effects<br/>Male<br/>Middle Aged<br/>Odds Ratio<br/>Pilot Projects<br/>Prospective Studies<br/>Proteinuria--prevention & control<br/>Risk Assessment<br/>Severity of Illness Index<br/>Time Factors<br/>Transforming Growth Factor beta--analysis<br/>Treatment Outcome<br/>Urinalysis